MarketPeel
Insider Trading Intelligence
WL

Westlake Biopartners Opportunity Gp I, Llc

KYTX
10% OWNER · KYVERNA THERAPEUTICS, INC. · CIK 0001811945
FILING MIX · LIFETIME43%/57%
BUYS
3
SELLS
4
TOTAL VALUE
$1000.0K
COMPANIES
1
ACTIVE SINCE
Feb 2024
HOLDINGS NOW
869,317
AVG SELL PX
TRADE KIND
SHOWING 7 / 7
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
1 backtested trades · 8 horizons · 2 pending
Forward-return performance of every backtestable P/S trade by Westlake Biopartners Opportunity Gp I, Llc, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d1+100.00%+28.43%+2.06%+26.37%+26.37%
14d1+100.00%+34.29%+0.81%+33.48%+33.48%
30d1+100.00%+19.43%+2.25%+17.18%+17.18%
60d1+100.00%+8.43%+0.94%+7.49%+7.49%
90d1+100.00%+22.00%-2.22%+24.22%+24.22%
180d1+100.00%+12.14%+11.58%+0.56%+0.56%
1y1(1 pending)
2y1(1 pending)
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
KYTX · 869,317 shares · as of Dec 18, 2025
0946,9851,893,9702,840,9553,787,9402025SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2024
2024
2024
2024
2025
2025
2025
2025
FLOW · 3 buys / 4 sellsCOVERAGE · 8 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
KYTX
KYVERNA THERAPEUTICS, INC.
PURCHASE
133,333$7.50$1000.0K869,317Dec 18, 2025Dec 22, 2025View →
KYTX
KYVERNA THERAPEUTICS, INC.
SALE
8,830,9010Feb 12, 2024Feb 14, 2024View →
KYTX
KYVERNA THERAPEUTICS, INC.
PURCHASE
735,984735,984Feb 12, 2024Feb 14, 2024View →
KYTX
KYVERNA THERAPEUTICS, INC.
PURCHASE
3,787,9403,787,940Feb 12, 2024Feb 14, 2024View →
KYTX
KYVERNA THERAPEUTICS, INC.
SALE
4,401,7710Feb 12, 2024Feb 14, 2024View →
KYTX
KYVERNA THERAPEUTICS, INC.
SALE
3,349,5380Feb 12, 2024Feb 14, 2024View →
KYTX
KYVERNA THERAPEUTICS, INC.
SALE
4,006,6240Feb 12, 2024Feb 14, 2024View →
Other insiders · KYTX
Loading peer insiders…
About this filer
CIK 0001811945
ROLE
10% Owner
PRIMARY
KYTX
COMPANIES
1
ACTIVE SINCE
Feb 2024
MARKETPEEL · /INSIDER/0001811945DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback